Zydus To Continue Mirabegron Sales
Looks To World-First Dual Shigella-Typhoid Vaccine
Zydus expects strong mirabegron sales in FY26 amid US litigation even as it builds a growth pillar in vaccines with a world-first, Gates Foundation-aided dual shigella-typhoid vaccine under development and others on the WHO prequalified list.
